Renowned New York Chef Introduces Line of Innovative Cannabis Edibles

–Breakthrough Patent-Pending Product Offers Fast-Acting Effect–

NEW YORK (May 30, 2018)—Ron Silver, Chef and Owner of popular New York City brunch destination Bubby’s, today announced the launch of Azuca, a line of fast-acting cannabis edibles and ingredients made from chef-quality, all-natural ingredients. The product suite—which leverages first-of-its-kind, patent-pending technology—will fill the cannabis industry’s demand for a trustworthy edible product that offers a fast-acting, consistent effect.

“Azuca is an idea that stems from both my career as a chef and entrepreneur, as well as my recognition of the cannabis industry’s critical need for trustworthy edibles, both for medical and adult use purposes. Edibles are notoriously unpredictable in their effects—you can never tell how long it will last, when it will hit, and its overall effect. We developed a way of resolving these issues so that the market finally has high-quality, artisan products. Our products taste great, and are safer and more predictable.” said Silver, Founder and Chief Creative Officer, Azuca.

Azuca launches with a variety of cannabis-infused sweeteners and syrups, which can be added to food and beverages as the building blocks of a sophisticated culinary cannabis experience. The product line includes a wide range of syrup flavors, such as almond, ginger, pomegranate, grapefruit and vanilla. Azuca products enable consumers to create their own flavor combinations.  Azuca sweeteners are available in varieties such as demerara cane sugar, maple sugar, coconut sugar, stevia, date sugar and agave.

Azuca CEO Kim Sanchez Rael added, “The combination of breakthrough science and culinary creativity is what makes Azuca truly unique. The launch of Azuca in New York today positions our brand as a leader in chef-created edibles and ingredients. Beyond New York, we are licensing our technology to partners in legal markets for the creation of our infused products.”

Azuca products are set apart by their fast-acting effects and high bioavailability. While an average edible can take 1 ½ hours or longer to take effect, Azuca works in 15-30 minutes. In terms of bioavailability, 18-22% of the active ingredient is metabolized with Azuca versus just 2-6% with competing edible products. This is achieved through a patent-pending technology, developed by Silver, which alters the shape of cannabis molecules to make them more water soluble, in turn allowing for more rapid, predictable and controllable effects.

Cannabidiol (CBD) Azuca products can be purchased in New York at Bubby’s restaurants inside lemonades, coffees or teas. In legal marijuana markets, Azuca will be launching THC-based products sold through licensed dispensaries, beginning in Massachusetts this summer.

# # #

About Azuca

Azuca is a privately-held, investor-backed cannabis company which commercializes a line of edible products using patent-pending technology. This technology alters the shape of C@^#!&*$ molecules in order to make them more water soluble, to increase bioavailability and effectiveness and minimize wait-time for more controlled, trustworthy edibles.

The Azuca product line consists of sweeteners and syrups which can be added to food and beverages as the building blocks of a sophisticated culinary cannabis experience. CBD products are anticipated to be available nationwide from summer 2018, while THC products will be launching through licensed dispensaries in legal markets.

The Cannabis Market

Azuca is tapping into the burgeoning cannabis market with its edible line. According to industry estimates, the legal cannabis market is expected to grow to $50 billion by 2026. Currently recreational use is legal in eight states, while medical marijuana is legal in 30 states, with edibles representing a fast-growing segment.  New adopters are often health conscious and averse to smoking and vaping, making cannabis edibles the ideal solution.

For more information or to schedule an interview, please contact Emily Kielthy at emily@rosengrouppr.com or 646.695.7045.